Literature DB >> 30370570

Orf virus: A promising new therapeutic agent.

Ruixue Wang1,2, Yong Wang1, Fang Liu2, Shuhong Luo1.   

Abstract

The orf virus (ORFV) is a zoonotic, epitheliotropic, DNA parapoxvirus that infects principally sheep and goats. Exposure of animals to the virus or immunization by an ORFV preparation can accentuate the severity of disease, which has provoked an interest in the underlying cellular, virological, and molecular mechanisms. The identified ORFV virulence genes and the fact that the virus can repeatedly infect a host, owing to its evasive mechanisms, contribute to the development of potent immune modulators in various animal species. ORFV has been developed as a vaccine in veterinary medicine. The unique host immune-evasion ability of ORFV has made it an important candidate for vaccine vectors and biological agents (as an oncolytic virus). Genetic modifications using ORFV to obtain safe and efficient preparations and mechanistic studies are improvements to the currently available methods for disease treatment.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  epidemiology; immunoregulation; immunotherapy; oncolysis; orf virus; vaccine

Mesh:

Substances:

Year:  2018        PMID: 30370570     DOI: 10.1002/rmv.2013

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  9 in total

1.  Orf Virus-Based Vectors Preferentially Target Professional Antigen-Presenting Cells, Activate the STING Pathway and Induce Strong Antigen-Specific T Cell Responses.

Authors:  Melanie Müller; Alena Reguzova; Markus W Löffler; Ralf Amann
Journal:  Front Immunol       Date:  2022-05-09       Impact factor: 8.786

2.  Establishment and characterization of transformed goat primary cells by expression of simian virus 40 large T antigen for orf virus propagations.

Authors:  Yumiko Yamada; Guan-Ru Liao; Ching-Yu Tseng; Yeu-Yang Tseng; Wei-Li Hsu
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

3.  Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccines Efficiently Protect Cockatiels Against Parrot Bornavirus Infection and Proventricular Dilatation Disease.

Authors:  Isabell Rall; Ralf Amann; Sara Malberg; Christiane Herden; Dennis Rubbenstroth
Journal:  Viruses       Date:  2019-12-06       Impact factor: 5.048

4.  Orf (Ecthyma Contagiosum) Transmitted from a Camel to a Human: A Case Report.

Authors:  Abdulmajeed Mohammed Alajlan; Najlaa Abdulrahman Alsubeeh
Journal:  Am J Case Rep       Date:  2020-12-23

5.  The Combined Use of Orf Virus and PAK4 Inhibitor Exerts Anti-tumor Effect in Breast Cancer.

Authors:  Hao Deng; Bin Xiao; Yinger Huang; Kongyan Weng; Jialing Chen; Kun Li; Hongfeng Wu; Shuhong Luo; Wenbo Hao
Journal:  Front Microbiol       Date:  2022-03-23       Impact factor: 5.640

6.  Genome-Wide Analysis and Molecular Characterization of Orf Virus Strain UPM/HSN-20 Isolated From Goat in Malaysia.

Authors:  Hassana Kyari Mangga; Jamilu Abubakar Bala; Krishnan Nair Balakrishnan; Alhaji Modu Bukar; Zaharaddeen Lawan; Auwal Gambo; Faez Firdaus Abdullah Jesse; Mustapha M Noordin; Mohd-Lila Mohd-Azmi
Journal:  Front Microbiol       Date:  2022-07-11       Impact factor: 6.064

7.  A Deeper Insight into Evolutionary Patterns and Phylogenetic History of ORF Virus through the Whole Genome Sequencing of the First Italian Strains.

Authors:  Elisabetta Coradduzza; Daria Sanna; Fabio Scarpa; Ilenia Azzena; Mariangela S Fiori; Rosario Scivoli; Angela M Rocchigiani; Roberto Bechere; Maria A Dettori; Davide Pintus; Eloisa Evangelista; Marco Casu; Ciriaco Ligios; Giantonella Puggioni
Journal:  Viruses       Date:  2022-07-04       Impact factor: 5.818

8.  Crystal structures of ORFV125 provide insight into orf virus-mediated inhibition of apoptosis.

Authors:  Chathura D Suraweera; Mark G Hinds; Marc Kvansakul
Journal:  Biochem J       Date:  2020-12-11       Impact factor: 3.857

9.  Inhibition of orf virus replication in goat skin fibroblast cells by the HSPA1B protein, as demonstrated by iTRAQ-based quantitative proteome analysis.

Authors:  Jun-Hong Hao; Han-Jin Kong; Ming-Hao Yan; Chao-Chao Shen; Guo-Wei Xu; Da-Jun Zhang; Ke-Shan Zhang; Hai-Xue Zheng; Xiang-Tao Liu
Journal:  Arch Virol       Date:  2020-09-02       Impact factor: 2.685

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.